In rheumatoid arthritis, synovial expression of urokinase (uPA) activi
ty is greatly increased (Busso, N., V. Peclat, A. So, and A.-P. Sappin
o, 1997. Ann. Rheum. Dis, 56:550-557), We report the same effect in mu
rine antigen-induced arthritis, uPA-mediated plasminogen activation in
arthritic joints may have deleterious effects via degradation of cart
ilage and bone matrix proteins as well as beneficial effects via fibri
n degradation. We evaluated these contrasting effects in vivo by analy
zing the phenotype of uPA-deficient (uPA(-/-)) and control mice during
antigen-induced arthritis. Joint inflammation was comparable in both
groups up to day 3 and subsequently declined in control mice, remainin
g significantly elevated in uPA(-/-) mice on days 10 and 30 after arth
ritis onset. Likewise, synovial thickness was markedly increased in uP
A-deficient mice persisting for up to 2 mo, whereas it subsided in con
trol animals. Bone erosion was exacerbated in uPA(-/-) mice on day 30.
By contrast, no difference in articular cartilage proteoglycan conten
t was found between both groups. Significantly increased accumulation
of fibrin was observed by day 30 in arthritic joints of uPA(-/-) mice.
We hypothesized that synovial fibrin deposition plays a role in joint
inflammation. Accordingly, defibrinogenation of uPA(-/-) mice by ancr
od significantly decreased the sustained joint inflammation. All the a
bove observations were reproducible in plasminogen-deficient (Pln(-/-)
) mice. In conclusion, synovial fibrin deposition plays a role as a no
nimmunological mechanism which sustains chronic arthritis.